Presentation is loading. Please wait.

Presentation is loading. Please wait.

Rapamycin in transplantation: A review of the evidence

Similar presentations


Presentation on theme: "Rapamycin in transplantation: A review of the evidence"— Presentation transcript:

1 Rapamycin in transplantation: A review of the evidence
Richard N. Saunders, Mathew S. Metcalfe, Michael L. Nicholson  Kidney International  Volume 59, Issue 1, Pages 3-16 (January 2001) DOI: /j x Copyright © 2001 International Society of Nephrology Terms and Conditions

2 Figure 1 Proposed mechanism of action for rapamycin. Abbreviations are: mTOR, mammalian target of rapamycin; IL, interleukin. Rapa inhibits (1) Phosphorylation of 4E-BP1, preventing release of eIF-4E and initiation of translation12,13; (2) P27-mediated activation of cdk2-cyclin E and synthesis of proteins important for cell cycle progression14; and (3) p70S6 kinase activation, limiting ribosomal protein S6 phosphorylation and reducing synthesis of ribosomal/translational proteins15,16. Kidney International  , 3-16DOI: ( /j x) Copyright © 2001 International Society of Nephrology Terms and Conditions


Download ppt "Rapamycin in transplantation: A review of the evidence"

Similar presentations


Ads by Google